The Rebound Phenomenon-Fact or Fancy?: Experience With Discontinuation of Long-Term Anticoagulation Therapy After Myocardial Infarction

Circulation - United States
doi 10.1161/01.cir.32.6.878
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Long-Term Persistence of Immunity After Hepatitis B Vaccination: A Fact, Not a Fancy

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2016English

Individual Long-Term Variation of Platelet Reactivity in Patients With Dual Antiplatelet Therapy After Myocardial Infarction

Platelets
MedicineHematology
2018English

Common Cold: Fact or Fancy?

BMJ
1958English

Long-Term Mortality After Stroke Is Higher Than After Myocardial Infarction

Neurological Sciences
DermatologyMedicinePsychiatryNeurologyMental Health
2016English

Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non Q-Wave Myocardial Infarction

Circulation
Cardiovascular MedicinePhysiologyCardiology
1999English

Immune Persistence After Hepatitis B Vaccination in Infancy – Fact or Fancy?

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2016English

Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy)Clinical Perspective

Circulation
Cardiovascular MedicinePhysiologyCardiology
2017English

(Summary of the Recommendations for Long-Term Secondary Prevention After Myocardial Infarction)

Cor et Vasa
Cardiovascular MedicineCardiology
2019English

Long-Term Mortality Risk in Hospitalized Patients With Heart Failure After Myocardial Infarction

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy